Skip to main content
Top
Published in: Acta Diabetologica 1/2016

01-02-2016 | Original Article

Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients

Authors: Maria Perticone, Eliezer J. Tassone, Paola E. Scarpino, Paola Naccarato, Desirée Addesi, Serena di Cello, Angela Sciacqua, Raffaele Maio, Michele Andreucci, Salvatore Carrao, Anna Licata, Giorgio Sesti, Francesco Perticone

Published in: Acta Diabetologica | Issue 1/2016

Login to get access

Abstract

Aims

Normoglucose tolerant (NGT) subjects with a 1-h postload plasma glucose (PLPG) value ≥155 mg/dL have an increased risk of type-2 diabetes and subclinical organ damage. Heart rate variability (HRV) reflects cardiac autonomic balance, frequently impaired in course of diabetes. At this time, no data support the association between 1-h PLPG and HRV; thus, we investigated the possible association between 1-h PLPG and HRV.

Methods

We enrolled 92 never-treated hypertensive subjects (56 women, 36 men), aged 55 ± 9.8 years. During OGTT, the patients underwent electrocardiographic recordings to evaluate HRV in the time domain (SDNN). Insulin sensitivity was assessed by Matsuda index.

Results

Among participants, 56 were NGT, 20 had impaired glucose tolerance (IGT), and 16 had type-2 diabetes. According to the 1-h PLPG cutoff point of 155 mg/dL, we divided NGT subjects into: NGT < 155 (n = 38) and NGT ≥ 155 (n = 18). Glucose tolerance status was associated with a significant (P < 0.0001) increase in PLPG and insulin and the reduction in Matsuda index. In all groups, the SDNN values significantly (P < 0.0001) decreased during the first hour of OGTT. A complete recovery in NGT groups was observed at the end of the second hour; in IGT and type-2 diabetes, SDNN remained significantly lower with respect to baseline values. At multiple regression analysis, Matsuda index resulted in the only determinant of SDNN modification, explaining the 12.3 % of its variability.

Conclusions

Our data demonstrate that during OGTT, sympathovagal balance is acutely affected by both glucose and insulin modifications. Particularly, NGT ≥ 155 subjects behave in the same way of IGT and type-2 diabetes patients.
Literature
1.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444CrossRefPubMed
2.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed
3.
go back to reference Kanaley JA, Baynard T, Franklin RM et al (2007) The effects of a glucose load and sympathetic challenge on autonomic function in obese women with and without type 2 diabetes mellitus. Metabolism 56:778–785PubMedCentralCrossRefPubMed Kanaley JA, Baynard T, Franklin RM et al (2007) The effects of a glucose load and sympathetic challenge on autonomic function in obese women with and without type 2 diabetes mellitus. Metabolism 56:778–785PubMedCentralCrossRefPubMed
4.
go back to reference Vinik AI, Erbas T (2001) Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928–944CrossRefPubMed Vinik AI, Erbas T (2001) Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928–944CrossRefPubMed
5.
go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRefPubMed Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRefPubMed
6.
go back to reference Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482–492CrossRefPubMed Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482–492CrossRefPubMed
7.
go back to reference Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart Rate Variability (1996) Standards of measurement physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart Rate Variability (1996) Standards of measurement physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef
8.
go back to reference Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedCentralCrossRefPubMed Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedCentralCrossRefPubMed
9.
go back to reference Holman RR, Paul SK, Bethel MA, Matthews DR, Neil AW (2008) 10-Year follow-up of intensive glucose control in type-2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMed Holman RR, Paul SK, Bethel MA, Matthews DR, Neil AW (2008) 10-Year follow-up of intensive glucose control in type-2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMed
10.
go back to reference Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 287:2570–2581CrossRefPubMed Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 287:2570–2581CrossRefPubMed
11.
go back to reference Lakka HM, Laaksonen DE, Lakka TA et al (2002) Metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA et al (2002) Metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed
12.
go back to reference DECODE (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef DECODE (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef
13.
go back to reference Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PWF (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25:1845–1850CrossRefPubMed Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PWF (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25:1845–1850CrossRefPubMed
14.
go back to reference Ceriello A (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54:1–7CrossRefPubMed Ceriello A (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54:1–7CrossRefPubMed
15.
go back to reference Ilercil A, Devereux RB, Roman MJ et al (2001) Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am Heart J 141:992–998CrossRefPubMed Ilercil A, Devereux RB, Roman MJ et al (2001) Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am Heart J 141:992–998CrossRefPubMed
16.
go back to reference Kurl S, Zaccardi F, Onaemo VN et al (2015) Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study. Acta Diabetol 52:183–186CrossRefPubMed Kurl S, Zaccardi F, Onaemo VN et al (2015) Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study. Acta Diabetol 52:183–186CrossRefPubMed
17.
go back to reference Bandello F, Lattanzio R, Zucchiatti I, Del Turco C (2013) Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol 50:1–20CrossRefPubMed Bandello F, Lattanzio R, Zucchiatti I, Del Turco C (2013) Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol 50:1–20CrossRefPubMed
18.
go back to reference Ciccacci C, Di Fusco D, Cacciotti L et al (2013) TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol 50:789–799CrossRefPubMed Ciccacci C, Di Fusco D, Cacciotti L et al (2013) TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol 50:789–799CrossRefPubMed
19.
go back to reference Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655PubMedCentralCrossRefPubMed Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655PubMedCentralCrossRefPubMed
20.
go back to reference Succurro E, Marini MA, Arturi F et al (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207:245–249CrossRefPubMed Succurro E, Marini MA, Arturi F et al (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207:245–249CrossRefPubMed
21.
go back to reference Succurro E, Arturi F, Lugarà M et al (2010) One-hour post load plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 5:1922–1927PubMedCentralCrossRefPubMed Succurro E, Arturi F, Lugarà M et al (2010) One-hour post load plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 5:1922–1927PubMedCentralCrossRefPubMed
22.
go back to reference Sciacqua A, Miceli S, Carullo G et al (2011) 1-h post load plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34:1–6CrossRef Sciacqua A, Miceli S, Carullo G et al (2011) 1-h post load plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34:1–6CrossRef
23.
go back to reference Sciacqua A, Miceli S, Greco L et al (2011) One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 34:2291–2296PubMedCentralCrossRefPubMed Sciacqua A, Miceli S, Greco L et al (2011) One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 34:2291–2296PubMedCentralCrossRefPubMed
24.
go back to reference O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:114–122 O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:114–122
25.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed
26.
go back to reference Perticone F, Sciacqua A, Perticone M et al (2013) Phenotypic characterization of normotolerant hypertensive patients. Int J Cardiol 165:322–326CrossRefPubMed Perticone F, Sciacqua A, Perticone M et al (2013) Phenotypic characterization of normotolerant hypertensive patients. Int J Cardiol 165:322–326CrossRefPubMed
27.
go back to reference Matsuda M, De Fronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed Matsuda M, De Fronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed
28.
go back to reference Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612PubMedCentralCrossRefPubMed Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612PubMedCentralCrossRefPubMed
29.
go back to reference Bikkina M, Larson MG, Levy D (1993) Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 22:1111–1116CrossRefPubMed Bikkina M, Larson MG, Levy D (1993) Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 22:1111–1116CrossRefPubMed
30.
go back to reference Ward KD, Sparrow D, Landsberg L, Young JB, Vokonas PS, Weiss ST (1995) Influence of insulin. Sympathetic nervous system activity and obesity on blood pressure: the normative aging study. J Hypertens 14:301–308CrossRef Ward KD, Sparrow D, Landsberg L, Young JB, Vokonas PS, Weiss ST (1995) Influence of insulin. Sympathetic nervous system activity and obesity on blood pressure: the normative aging study. J Hypertens 14:301–308CrossRef
31.
go back to reference Berne C, Fagius J, Pollare T, Hjelmdahl P (1992) The sympathetic response to euglycaemic hyperinsulinaemia: the evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35:873–879CrossRefPubMed Berne C, Fagius J, Pollare T, Hjelmdahl P (1992) The sympathetic response to euglycaemic hyperinsulinaemia: the evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35:873–879CrossRefPubMed
32.
go back to reference Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L (2006) Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovas Disorders 6:19CrossRef Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L (2006) Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovas Disorders 6:19CrossRef
33.
go back to reference Hoffman RP, Hausberg M, Sinkey CA, Anderson EA (1999) Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Diabetes Complications 13:17–22CrossRefPubMed Hoffman RP, Hausberg M, Sinkey CA, Anderson EA (1999) Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Diabetes Complications 13:17–22CrossRefPubMed
Metadata
Title
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients
Authors
Maria Perticone
Eliezer J. Tassone
Paola E. Scarpino
Paola Naccarato
Desirée Addesi
Serena di Cello
Angela Sciacqua
Raffaele Maio
Michele Andreucci
Salvatore Carrao
Anna Licata
Giorgio Sesti
Francesco Perticone
Publication date
01-02-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0740-1

Other articles of this Issue 1/2016

Acta Diabetologica 1/2016 Go to the issue

Thanks to Reviewer

Thanks to Reviewer 2015

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.